An assessment of the urinary function and the comfort of life in patients after endometrial cancer combined treatment
Affiliation and adress for correspondence
1 Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialist Hospital, Krakow, Poland. Head: Marcin Opławski, MD, PhD
2 Department of Gynecologic Oncology, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Division in Krakow, Poland. Head: Paweł Blecharz, MD, PhD
Correspondence: Marcin Opławski, MD, PhD, Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialist Hospital, Złotej Jesieni 1, 31-826 Kraków, Poland, tel.: +48 500 177 291, e-mail: oplawski.m@gmail.com
Curr Gynecol Oncol 2015, 13 (2), p. 78–84
DOI: 10.15557/CGO.2015.0009
ABSTRACT

Endometrial cancer is currently the most common form of female reproductive tract tumors. The efficacy of treatment, which involves surgery, radiotherapy and systemic therapy, is increasing and the assessment of the quality of life of patients is subject to careful analysis. Difficulty in urination represents a major factor reducing the quality of life of patients. The aim of the study was to collect data on the urinary functioning and the quality of life in endometrial cancer patients considered cured after a combined treatment compared to patients after non-oncological hysterectomy. A total of 46 females divided into two groups were included in the study. Group I (study group) included 23 endometrial cancer patients (stage IA, G1–G2) after combined treatment, who received surgical treatment and adjuvant brachytherapy; group II (control group) included 23 patients after non-oncological hysterectomy and uterine appendage removal. The patients were assessed once, between month 6 and 12 after treatment termination. Medical history, gynecologic examination, urodynamic testing and life quality assessment were performed in all patients. Statistical analysis showed a significant difference between the two groups in terms of urogynecologic outcomes (p = 0.0193). The proportion of women without any disturbances was definitely higher in the control group (only 22%) vs. study group. Stress urinary incontinence, mixed incontinence and overactive bladder were more common in the study group compared to controls. Furthermore, a significant difference in the quality of life was shown between the compared groups of patients (p = 0.0270). Reduced quality of life was significantly more common in the study group (57% vs. 26% of controls). Improvement of life quality was less common in the study group (13%) compared to controls (28%). Brachytherapy increases the severity of genitourinary disorders, which adversely affects the quality of life in patients after cancer therapy.

Keywords: endometrial cancer, brachytherapy, stress urinary incontinence, urodynamic testing, overactive bladder, mixed incontinence